Bayer Crop Science has received a penalty order of Rs. 1.55 million from the Office of the Superintendent of Central Tax, Amaravathi CGST Division, Guntur, Vishakapatnam, Andhra Pradesh. The penalty relates to Goods and Services Tax (GST) on Outward Supply for the Financial Year 2018-19.

Penalty Details

The company disclosed the following information regarding the penalty:

Company's Response

Bayer Crop Science has stated that the order is currently appealable. The company plans to make an assessment to exercise its right to appeal against the penalty. This approach suggests that Bayer Crop Science may challenge the order if they believe there are grounds for contesting the penalty.

Regulatory Compliance

The company made this disclosure in compliance with Regulation 30 of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements Regulations, 2015. The disclosure was communicated to BSE Limited on December 16, 2025, through a formal letter signed by Company Secretary and Compliance Officer Bharati Shetty.

Potential Impact

While the penalty amount of Rs. 1.55 million represents a regulatory compliance matter, the full financial impact on Bayer Crop Science will depend on the outcome of any potential appeal process. The company has indicated it will assess its options for challenging the order through appropriate legal channels.

Bayer Crop Science , a prominent player in the agricultural sector, has received a revised order from the Additional Commissioner of Central Tax, GST Commissionerate, Belagavi, Karnataka. This new order significantly reduces the penalty imposed on the company related to GST on Outward Supply for the Financial Year 2017-18.

Key Points of the Revised Order

Background and Implications

The revised order pertains to GST on Outward Supply for the Financial Year 2017-18, a period that saw the implementation of the Goods and Services Tax (GST) in India. This substantial reduction in penalty could have positive implications for Bayer CropScience's financial outlook.

Company's Response

While the penalty has been significantly reduced, Bayer CropScience is currently evaluating its options. The company has stated that it will assess whether to exercise its right to appeal the revised order. This cautious approach suggests that the company is carefully considering its legal and financial strategies moving forward.

Investor Considerations

For investors and stakeholders in Bayer CropScience, this development presents a mixed scenario:

1. Positive Aspect: The significant reduction in penalty amount is likely to be viewed favorably, as it reduces the financial burden on the company.
2. Ongoing Uncertainty: The company's consideration of further appeal indicates that there might be more developments in this matter.

Investors should keep a close eye on any future announcements from Bayer CropScience regarding this issue, as it may have implications for the company's financial statements and regulatory compliance strategies.

Broader Context

This case highlights the complex nature of GST compliance in India, especially in the initial years of its implementation. It also underscores the importance of robust tax management strategies for companies operating in the Indian market.

As the GST regime continues to evolve, companies like Bayer CropScience may face similar challenges. How they navigate these regulatory waters can have significant impacts on their financial health and market perception.

Stakeholders will be watching closely to see how Bayer CropScience proceeds with this matter and how it might affect the company's overall financial performance in the coming quarters.